Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Months 5 through 12 are the primary weight loss phase
Food and Drug Administration (FDA) for the treatment of type 1 diabetes, they could potentially have benefits for people with that condition too
As Kailera prepares to advance KAI-9531 into a global clinical program, we look forward to evaluating both higher doses and longer duration of treatment to expand on KAI-9531s best-in-class potential, said Ron Renaud, President and Chief Executive Officer of Kailera
Our guide covers injection site reactions, metabolic changes, and practical management strategies
That is consistent with Novos own low single digit negative guidance for 2026 global sales growth
US$ 29.88
US$ 20.51
US$ 26.42
US$ 28.65
US$ 22.47
US$ 25.57
US$ 24.71
US$ 28.80
US$ 20.96
US$ 22.89
US$ 22.43
